【美股异动 | 礼来(LLY.US)涨逾4% Jaypirca上市申请提交至欧盟委员会】智通财经APP获悉,周五,礼来(LLY.US)涨逾4%,报1177.67美元。消息面上,6月26日,礼来宣布,欧洲药品管理局人用药品委员会CHMP已推荐批准其非共价布鲁顿酪氨酸激酶BTK抑制剂Jaypirca,用于治疗接受过或未接受过BTK抑制剂治疗的成人慢性淋巴细胞白血病CLL患者,该推荐涵盖该适应症的全线治疗,并已递交至欧盟委员会进行最终审批。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.